Biosergen Issues Shares as Compensation to Rights Issue Guarantors
Biosergen AB has resolved to issue 496,150 shares to guarantors Tuvedalen Limited and Christian Horsdal as compensation for their role in a completed rights issue. The decision was made on September 10, 2026.
Biosergen AB (publ) announced on September 10, 2026, its resolution to issue 496,150 shares to guarantors Tuvedalen Limited and Christian Horsdal. These shares will serve as compensation for their guarantee commitment in connection with the company's previously resolved rights issue.
The decision was made by the Board of Directors, acting under the authority granted by the extraordinary general meeting on August 6, 2026. The guarantors opted to receive their remuneration in the form of newly issued Biosergen shares. The subscription price for these shares matches the terms set for the original rights issue.
This share issuance is part of Biosergen's broader financial strategy to strengthen its capital base and support ongoing operations. Compensating guarantors with shares is a common practice in capital raises, allowing companies to conserve cash.
The company is expected to provide further updates on its operational and financial developments. Details regarding the share issuance and its impact on the company's ownership structure will be disclosed in due course.